Approvals/TGA/EXFORGE HCT 10/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

Approved

STANDARD

EXFORGE HCT 10/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

Approval Id: 407b09fab2c9558b
Product Name: EXFORGE HCT 10/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Artg Id: 158164
Artg Name: EXFORGE HCT 10/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2010-04-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-07462-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-07459-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

407b09fab2c9558b

Type

Standard